Ito M, Hamako J, Sakurai Y, Matsumoto M, Fujimura Y, Suzuki M, Hashimoto K, Titani K, Matsui T
Division of Biomedical Polymer Science, Institute for Comprehensive Medical Science, Fujita Health University, Toyoake, Aichi 470-1192, Japan.
Biochemistry. 2001 Apr 10;40(14):4503-11. doi: 10.1021/bi0022700.
The primary structure of kaouthiagin, a metalloproteinase from the venom of the cobra snake Naja kaouthia which specifically cleaves human von Willebrand factor (VWF), was determined by amino acid sequencing. Kaouthiagin is composed of 401 amino acid residues and one Asn-linked sugar chain. The sequence is highly similar to those of high-molecular mass snake venom metalloproteinases from viperid and crotalid venoms comprised of metalloproteinase, disintegrin-like, and Cys-rich domains. The metalloproteinase domain had a zinc-binding motif (HEXXHXXGXXH), which is highly conserved in the metzincin family. Kaouthiagin had an HDCD sequence in the disintegrin-like domain and uniquely had an RGD sequence in the Cys-rich domain. Metalloproteinase-inactivated kaouthiagin had no effect on VWF-induced platelet aggregation but still had an inhibitory effect on the collagen-induced platelet aggregation with an IC(50) of 0.2 microM, suggesting the presence of disintegrin-like activity in kaouthiagin. To examine the effects of these HDCD and RGD sequences, we prepared synthetic peptides cyclized by an S-S linkage. Both the synthetic cyclized peptides from the disintegrin-like domain and from the Cys-rich domain) had an inhibitory effect on collagen-induced platelet aggregation with IC(50) values of approximately 90 and approximately 4.5 microM, respectively. The linear peptide (RAAKHDCDLPELC) and the cyclized peptide had little effect on collagen-induced platelet aggregation. These results suggest that kaouthiagin not only inhibits VWF-induced platelet aggregation by cleaving VWF but also disturbs the agonist-induced platelet aggregation by both the disintegrin-like domain and the RGD sequence in the Cys-rich domain. Furthermore, our results imply that the corresponding part of the Cys-rich domain in other snake venom metalloproteinases also has a synergistic disturbing effect on platelet aggregation, serving as a second disintegrin-like domain. This is the first report of an elapid venom metalloproteinase with two disintegrin-like sequences.
通过氨基酸测序确定了考替阿金(kaouthiagin)的一级结构,考替阿金是眼镜蛇(Naja kaouthia)毒液中的一种金属蛋白酶,可特异性切割人血管性血友病因子(VWF)。考替阿金由401个氨基酸残基和一条天冬酰胺连接的糖链组成。其序列与蝰蛇科和响尾蛇科毒液中的高分子量蛇毒金属蛋白酶高度相似,这些金属蛋白酶由金属蛋白酶结构域、解整合素样结构域和富含半胱氨酸的结构域组成。金属蛋白酶结构域具有一个锌结合基序(HEXXHXXGXXH),在金属锌蛋白酶家族中高度保守。考替阿金在解整合素样结构域有HDCD序列,且在富含半胱氨酸的结构域独特地具有RGD序列。金属蛋白酶失活的考替阿金对VWF诱导的血小板聚集没有影响,但对胶原诱导的血小板聚集仍有抑制作用,IC(50)为0.2微摩尔,这表明考替阿金存在解整合素样活性。为了研究这些HDCD和RGD序列的作用,我们制备了通过S-S键环化的合成肽。来自解整合素样结构域和富含半胱氨酸结构域的合成环化肽对胶原诱导的血小板聚集均有抑制作用,IC(50)值分别约为90微摩尔和约4.5微摩尔。线性肽(RAAKHDCDLPELC)和环化肽对胶原诱导的血小板聚集几乎没有影响。这些结果表明,考替阿金不仅通过切割VWF抑制VWF诱导的血小板聚集,还通过解整合素样结构域和富含半胱氨酸结构域中的RGD序列干扰激动剂诱导的血小板聚集。此外,我们的结果表明,其他蛇毒金属蛋白酶中富含半胱氨酸结构域的相应部分对血小板聚集也有协同干扰作用,可作为第二个解整合素样结构域。这是关于具有两个解整合素样序列的眼镜蛇科毒液金属蛋白酶的首次报道。